AUNA's 4Q25 Financial Results Echo Ongoing Mexico Struggles and Leverage Pressures

What happened

AUNA S.A. announced its fourth quarter and full-year 2025 financial results on March 10, 2026, as reported in a Business Wire release. The DeepValue master report highlights that the company has been grappling with operational disruptions in Mexico, where 3Q25 revenue fell 12% year-over-year and Adjusted EBITDA dropped 29%, driven by IT system issues at Doctors Hospital. Leverage remains elevated at approximately 3.6x Net Debt/EBITDA, and management's plan to invest $500 million in Mexico over 3-5 years introduces dilution risk if equity financing is pursued. The new results likely reflect these persistent challenges, though the provided news content is truncated, limiting detailed assessment. Investors must now verify whether 4Q25 shows meaningful progress in Mexico's operational recovery or further strain on the balance sheet.

Implication

The 4Q25 results arrive as AUNA faces a pivotal moment where sequential volume gains in Mexico must convert into year-over-year revenue and EBITDA growth to validate the investment thesis. High leverage at ~3.6x Net Debt/EBITDA constrains financial flexibility, especially with a $500 million Mexico expansion plan that could necessitate equity financing, risking shareholder dilution. Investors should scrutinize the company's ability to resolve IT disruptions and improve utilization metrics, as these are essential for deleveraging and re-rating. Any announcement of dilutive funding tied to the expansion plan would heighten downside risks, while sustained operational improvements could offer upside but require clear, auditable KPIs. Until such evidence emerges, the stock remains a high-risk, wait-and-see opportunity with limited margin of safety.

Thesis delta

The new results do not shift the core thesis, which remains dependent on Mexico operational recovery and leverage reduction without equity dilution. However, if 4Q25 data reveals continued revenue declines or hints at imminent dilutive financing, it could accelerate bear-case scenarios, whereas unexpected strength might provide temporary relief but not yet justify a rating change without follow-through.